Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acute virus hepatitis - infection hygiene recommendations based on current knowledge].

R Baumgarten

    Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
    |April 15, 1983
    PubMed
    Summary

    Infectious hepatitis encompasses multiple pathogens, including hepatitis A, B, and non-A/non-B, each requiring distinct infection control measures. Differentiating non-A/non-B hepatitis and managing chronic hepatitis B carriers remain significant challenges.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Toolbox for atomic layer deposition process development on high surface area powders.

    The Review of scientific instruments·2021
    Same author

    Risk factors for the development of lithium-induced polyuria.

    The British journal of psychiatry : the journal of mental science·2003
    Same author

    Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial.

    Liver·2001
    Same author

    Dissociation between urine osmolality and urinary excretion of aquaporin-2 in healthy volunteers.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2000
    Same author

    Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation.

    Gut·2000
    Same author

    Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF).

    European journal of medical research·1999

    Area of Science:

    • Hepatology
    • Infectious Diseases
    • Virology

    Context:

    • The collective term "infectious hepatitis" historically encompasses diseases caused by at least three distinct viral agents.
    • Hepatitis A and B are well-defined, but differentiating pathogens for hepatitis non-A/non-B requires standardized diagnostic methods.
    • Clinical and epidemiological behaviors, along with infectiousness duration and transmission routes, vary significantly among hepatitis viruses.

    Purpose:

    • To differentiate the various causative agents of infectious hepatitis.
    • To outline distinct clinical and epidemiological characteristics of different hepatitis viruses.
    • To define appropriate infection-hygiene measures, immunoprophylaxis, and hospital hygiene protocols based on specific hepatitis types.

    Summary:

    Related Experiment Videos

  • Infectious hepatitis comprises diseases caused by at least three pathogens, including hepatitis A, B, and non-A/non-B, with the latter lacking definitive pathogen differentiation.
  • No cross-immunity exists between these viral hepatitides, necessitating tailored infection-hygienic measures considering varying infectiousness, transmission routes, and clinical presentations.
  • Management strategies address hospital hygiene, immunoprophylaxis, and isolation of patients, particularly those in food-supply or childcare roles, with ongoing challenges in chronic hepatitis B carrier management and legal regulations.

    • Impact:

    • Informed clinical decision-making for managing diverse hepatitis infections.
    • Development of targeted infection control strategies to prevent transmission in healthcare and community settings.
    • Highlights the need for advanced diagnostic tools for hepatitis non-A/non-B and improved protocols for chronic hepatitis B carriers.